Physician profile
Ishwer Patel
NPI 1447787759
$1,148.49
in general payments reported to CMS, 2019-2025
12 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $11.71 · 2021: $137 · 2022: $95.80 · 2023: $97.42 · 2024: $125 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.15 | 2019 | |
| Gilead Sciences, INC. | $165.42 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $124.98 | 2024 | Cobenfy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.41 | 2021-2023 | Lifevest |
| Axsome Therapeutics, INC. | $115.18 | 2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.09 | 2019 | |
| Pfizer INC. | $69.71 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $38.93 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $23.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.90 | 2021 | |
| Lilly USA, LLC | $15.17 | 2021 | |
| Merck Sharp & Dohme LLC | $13.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ishwer Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.